DIVERSIFIED HEALTHCARE TRUST (DHC) Fundamental Analysis & Valuation

NASDAQ:DHC • US25525P1075

Current stock price

6.71 USD
-0.44 (-6.15%)
At close:
6.7568 USD
+0.05 (+0.7%)
After Hours:

This DHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. DHC Profitability Analysis

1.1 Basic Checks

  • In the past year DHC has reported negative net income.
  • DHC had a negative operating cash flow in the past year.
  • In the past 5 years DHC reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: DHC reported negative operating cash flow in multiple years.
DHC Yearly Net Income VS EBIT VS OCF VS FCFDHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M

1.2 Ratios

  • DHC's Return On Assets of -6.56% is on the low side compared to the rest of the industry. DHC is outperformed by 84.55% of its industry peers.
  • With a Return On Equity value of -17.16%, DHC is not doing good in the industry: 80.49% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -6.56%
ROE -17.16%
ROIC N/A
ROA(3y)-6.38%
ROA(5y)-3.36%
ROE(3y)-16.21%
ROE(5y)-8.53%
ROIC(3y)N/A
ROIC(5y)N/A
DHC Yearly ROA, ROE, ROICDHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 -10 -15

1.3 Margins

  • The Gross Margin of DHC (18.11%) is worse than 91.87% of its industry peers.
  • DHC's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for DHC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.03%
GM growth 5Y-5.67%
DHC Yearly Profit, Operating, Gross MarginsDHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

3

2. DHC Health Analysis

2.1 Basic Checks

  • DHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • DHC has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, DHC has more shares outstanding
  • DHC has a better debt/assets ratio than last year.
DHC Yearly Shares OutstandingDHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
DHC Yearly Total Debt VS Total AssetsDHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • DHC has an Altman-Z score of -0.22. This is a bad value and indicates that DHC is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of DHC (-0.22) is worse than 76.42% of its industry peers.
  • DHC has a Debt/Equity ratio of 1.44. This is a high value indicating a heavy dependency on external financing.
  • DHC has a Debt to Equity ratio (1.44) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF N/A
Altman-Z -0.22
ROIC/WACCN/A
WACC9.07%
DHC Yearly LT Debt VS Equity VS FCFDHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • DHC has a Current Ratio of 1.56. This is a normal value and indicates that DHC is financially healthy and should not expect problems in meeting its short term obligations.
  • DHC's Current ratio of 1.56 is amongst the best of the industry. DHC outperforms 82.93% of its industry peers.
  • DHC has a Quick Ratio of 1.56. This is a normal value and indicates that DHC is financially healthy and should not expect problems in meeting its short term obligations.
  • DHC has a Quick ratio of 1.56. This is amongst the best in the industry. DHC outperforms 83.74% of its industry peers.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.56
DHC Yearly Current Assets VS Current LiabilitesDHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

3

3. DHC Growth Analysis

3.1 Past

  • The earnings per share for DHC have decreased by -4.76% in the last year.
  • Looking at the last year, DHC shows a small growth in Revenue. The Revenue has grown by 2.84% in the last year.
  • Measured over the past years, DHC shows a decrease in Revenue. The Revenue has been decreasing by -1.18% on average per year.
EPS 1Y (TTM)-4.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)2.84%
Revenue growth 3Y6.21%
Revenue growth 5Y-1.18%
Sales Q2Q%-0.01%

3.2 Future

  • DHC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.95% yearly.
  • Based on estimates for the next years, DHC will show a small growth in Revenue. The Revenue will grow by 4.03% on average per year.
EPS Next Y49.5%
EPS Next 2Y23.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.55%
Revenue Next 2Y4.03%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DHC Yearly Revenue VS EstimatesDHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
DHC Yearly EPS VS EstimatesDHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1

1

4. DHC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DHC. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DHC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DHC Price Earnings VS Forward Price EarningsDHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

  • DHC's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. DHC is more expensive than 67.48% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.28
DHC Per share dataDHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • DHC's earnings are expected to grow with 23.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.95%
EPS Next 3YN/A

2

5. DHC Dividend Analysis

5.1 Amount

  • DHC has a yearly dividend return of 0.54%, which is pretty low.
  • Compared to an average industry Dividend Yield of 7.30, DHC's dividend is way lower than its industry peers. On top of this 93.50% of the companies listed in the same industry pay a better dividend than DHC!
  • With a Dividend Yield of 0.54, DHC pays less dividend than the S&P500 average, which is at 1.91.
Industry RankSector Rank
Dividend Yield 0.54%

5.2 History

  • The dividend of DHC decreases each year by -25.96%.
  • DHC has paid a dividend for at least 10 years, which is a reliable track record.
  • DHC has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-25.96%
Div Incr Years0
Div Non Decr Years3
DHC Yearly Dividends per shareDHC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • DHC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-3.38%
EPS Next 2Y23.95%
EPS Next 3YN/A
DHC Yearly Income VS Free CF VS DividendDHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M

DHC Fundamentals: All Metrics, Ratios and Statistics

DIVERSIFIED HEALTHCARE TRUST

NASDAQ:DHC (3/20/2026, 8:00:01 PM)

After market: 6.7568 +0.05 (+0.7%)

6.71

-0.44 (-6.15%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-23
Earnings (Next)05-04
Inst Owners79.52%
Inst Owner Change3.04%
Ins Owners0.48%
Ins Owner Change-8.52%
Market Cap1.62B
Revenue(TTM)1.54B
Net Income(TTM)-285.89M
Analysts74.29
Price Target5.87 (-12.52%)
Short Float %2.87%
Short Ratio3.1
Dividend
Industry RankSector Rank
Dividend Yield 0.54%
Yearly Dividend0.04
Dividend Growth(5Y)-25.96%
DP-3.38%
Div Incr Years0
Div Non Decr Years3
Ex-Date01-26
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-82.03%
Min EPS beat(2)-213.15%
Max EPS beat(2)49.08%
EPS beat(4)2
Avg EPS beat(4)-28.15%
Min EPS beat(4)-213.15%
Max EPS beat(4)122.5%
EPS beat(8)3
Avg EPS beat(8)-9.87%
EPS beat(12)5
Avg EPS beat(12)-4.94%
EPS beat(16)5
Avg EPS beat(16)-13.8%
Revenue beat(2)1
Avg Revenue beat(2)-1.84%
Min Revenue beat(2)-4.35%
Max Revenue beat(2)0.67%
Revenue beat(4)1
Avg Revenue beat(4)-1.05%
Min Revenue beat(4)-4.35%
Max Revenue beat(4)0.67%
Revenue beat(8)2
Avg Revenue beat(8)-0.93%
Revenue beat(12)4
Avg Revenue beat(12)-0.74%
Revenue beat(16)5
Avg Revenue beat(16)-0.93%
PT rev (1m)0%
PT rev (3m)9.52%
EPS NQ rev (1m)-3.45%
EPS NQ rev (3m)-3.45%
EPS NY rev (1m)4.35%
EPS NY rev (3m)4.35%
Revenue NQ rev (1m)-4.49%
Revenue NQ rev (3m)-4.31%
Revenue NY rev (1m)-1.05%
Revenue NY rev (3m)-0.74%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.06
P/FCF N/A
P/OCF N/A
P/B 0.98
P/tB 0.98
EV/EBITDA 17.28
EPS(TTM)-1.1
EYN/A
EPS(NY)-0.56
Fwd EYN/A
FCF(TTM)-0.69
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS6.35
BVpS6.88
TBVpS6.88
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.56%
ROE -17.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.11%
FCFM N/A
ROA(3y)-6.38%
ROA(5y)-3.36%
ROE(3y)-16.21%
ROE(5y)-8.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.03%
GM growth 5Y-5.67%
F-Score6
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF N/A
Debt/EBITDA 10.3
Cap/Depr 56.06%
Cap/Sales 9.55%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 1.56
Altman-Z -0.22
F-Score6
WACC9.07%
ROIC/WACCN/A
Cap/Depr(3y)69.85%
Cap/Depr(5y)90%
Cap/Sales(3y)13.23%
Cap/Sales(5y)17.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y49.5%
EPS Next 2Y23.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.84%
Revenue growth 3Y6.21%
Revenue growth 5Y-1.18%
Sales Q2Q%-0.01%
Revenue Next Year2.55%
Revenue Next 2Y4.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y45.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1793.22%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-86.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-117.48%
OCF growth 3YN/A
OCF growth 5YN/A

DIVERSIFIED HEALTHCARE TRUST / DHC Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DIVERSIFIED HEALTHCARE TRUST?

ChartMill assigns a fundamental rating of 2 / 10 to DHC.


Can you provide the valuation status for DIVERSIFIED HEALTHCARE TRUST?

ChartMill assigns a valuation rating of 1 / 10 to DIVERSIFIED HEALTHCARE TRUST (DHC). This can be considered as Overvalued.


How profitable is DIVERSIFIED HEALTHCARE TRUST (DHC) stock?

DIVERSIFIED HEALTHCARE TRUST (DHC) has a profitability rating of 0 / 10.


Can you provide the financial health for DHC stock?

The financial health rating of DIVERSIFIED HEALTHCARE TRUST (DHC) is 3 / 10.


Can you provide the expected EPS growth for DHC stock?

The Earnings per Share (EPS) of DIVERSIFIED HEALTHCARE TRUST (DHC) is expected to grow by 49.5% in the next year.